348 related articles for article (PubMed ID: 18028781)
21. A20 suppresses hepatocellular carcinoma proliferation and metastasis through inhibition of Twist1 expression.
Chen H; Hu L; Luo Z; Zhang J; Zhang C; Qiu B; Dong L; Tan Y; Ding J; Tang S; Shen F; Li Z; Wang H
Mol Cancer; 2015 Nov; 14():186. PubMed ID: 26538215
[TBL] [Abstract][Full Text] [Related]
22. ABINs: A20 binding inhibitors of NF-kappa B and apoptosis signaling.
Verstrepen L; Carpentier I; Verhelst K; Beyaert R
Biochem Pharmacol; 2009 Jul; 78(2):105-14. PubMed ID: 19464428
[TBL] [Abstract][Full Text] [Related]
23. Intron-derived aberrant splicing of A20 transcript in rheumatoid arthritis.
Yoon HK; Byun HS; Lee H; Jeon J; Lee Y; Li Y; Jin EH; Kim J; Hong JH; Kim JH; Seok JH; Kang SW; Lee WH; Hur GM
Rheumatology (Oxford); 2013 Mar; 52(3):427-37. PubMed ID: 23148088
[TBL] [Abstract][Full Text] [Related]
24. The seventh zinc finger motif of A20 is required for the suppression of TNF-α-induced apoptosis.
Yamaguchi N; Yamaguchi N
FEBS Lett; 2015 May; 589(12):1369-75. PubMed ID: 25911380
[TBL] [Abstract][Full Text] [Related]
25. Adenovirus-mediated expression of a dominant negative mutant of p65/RelA inhibits proinflammatory gene expression in endothelial cells without sensitizing to apoptosis.
Soares MP; Muniappan A; Kaczmarek E; Koziak K; Wrighton CJ; Steinhäuslin F; Ferran C; Winkler H; Bach FH; Anrather J
J Immunol; 1998 Nov; 161(9):4572-82. PubMed ID: 9794384
[TBL] [Abstract][Full Text] [Related]
26. Expressions of nuclear factor kappaB, inducible nitric oxide synthase, and vascular endothelial growth factor in adenoid cystic carcinoma of salivary glands: correlations with the angiogenesis and clinical outcome.
Zhang J; Peng B; Chen X
Clin Cancer Res; 2005 Oct; 11(20):7334-43. PubMed ID: 16243805
[TBL] [Abstract][Full Text] [Related]
27. An inhibitory effect of A20 on NF-kappaB activation in airway epithelium upon influenza virus infection.
Onose A; Hashimoto S; Hayashi S; Maruoka S; Kumasawa F; Mizumura K; Jibiki I; Matsumoto K; Gon Y; Kobayashi T; Takahashi N; Shibata Y; Abiko Y; Shibata T; Shimizu K; Horie T
Eur J Pharmacol; 2006 Jul; 541(3):198-204. PubMed ID: 16765340
[TBL] [Abstract][Full Text] [Related]
28. Expression of CYLD, NF-kappaB and NF-kappaB-related factors in salivary gland tumors.
Fukuda M; Fukuda F; Horiuchi Y; Oku Y; Suzuki S; Kusama K; Sakashita H
In Vivo; 2006; 20(4):467-72. PubMed ID: 16900776
[TBL] [Abstract][Full Text] [Related]
29. A20 blocks endothelial cell activation through a NF-kappaB-dependent mechanism.
Cooper JT; Stroka DM; Brostjan C; Palmetshofer A; Bach FH; Ferran C
J Biol Chem; 1996 Jul; 271(30):18068-73. PubMed ID: 8663499
[TBL] [Abstract][Full Text] [Related]
30. A20/TNFAIP3 inhibits NF-κB activation induced by the Kaposi's sarcoma-associated herpesvirus vFLIP oncoprotein.
Sakakibara S; Espigol-Frigole G; Gasperini P; Uldrick TS; Yarchoan R; Tosato G
Oncogene; 2013 Mar; 32(10):1223-32. PubMed ID: 22525270
[TBL] [Abstract][Full Text] [Related]
31. A20/TNFAIP3, a new estrogen-regulated gene that confers tamoxifen resistance in breast cancer cells.
Vendrell JA; Ghayad S; Ben-Larbi S; Dumontet C; Mechti N; Cohen PA
Oncogene; 2007 Jul; 26(32):4656-67. PubMed ID: 17297453
[TBL] [Abstract][Full Text] [Related]
32. BRD4 inhibition suppresses cell growth, migration and invasion of salivary adenoid cystic carcinoma.
Wang L; Wu X; Wang R; Yang C; Li Z; Wang C; Zhang F; Yang P
Biol Res; 2017 May; 50(1):19. PubMed ID: 28545522
[TBL] [Abstract][Full Text] [Related]
33. [The effect of GDNF on matrix-degrading and cell-adhesion during perineural invasion of salivary adenoid cystic carcinoma].
Zheng SC; Zhang YR; Luo SY; Zhang LP
Shanghai Kou Qiang Yi Xue; 2016 Apr; 25(2):212-6. PubMed ID: 27329888
[TBL] [Abstract][Full Text] [Related]
34. A20 is a potent inhibitor of TLR3- and Sendai virus-induced activation of NF-kappaB and ISRE and IFN-beta promoter.
Wang YY; Li L; Han KJ; Zhai Z; Shu HB
FEBS Lett; 2004 Oct; 576(1-2):86-90. PubMed ID: 15474016
[TBL] [Abstract][Full Text] [Related]
35. A20 zinc finger protein inhibits TNF and IL-1 signaling.
Jäättelä M; Mouritzen H; Elling F; Bastholm L
J Immunol; 1996 Feb; 156(3):1166-73. PubMed ID: 8557994
[TBL] [Abstract][Full Text] [Related]
36. A20 inhibits NF-kappa B activation downstream of multiple Map3 kinases and interacts with the I kappa B signalosome.
Zetoune FS; Murthy AR; Shao Z; Hlaing T; Zeidler MG; Li Y; Vincenz C
Cytokine; 2001 Sep; 15(6):282-98. PubMed ID: 11594795
[TBL] [Abstract][Full Text] [Related]
37. Tumor necrosis factor-alpha-induced protein 3 as a putative regulator of nuclear factor-kappaB-mediated resistance to O6-alkylating agents in human glioblastomas.
Bredel M; Bredel C; Juric D; Duran GE; Yu RX; Harsh GR; Vogel H; Recht LD; Scheck AC; Sikic BI
J Clin Oncol; 2006 Jan; 24(2):274-87. PubMed ID: 16365179
[TBL] [Abstract][Full Text] [Related]
38. The cytokine-inducible zinc finger protein A20 inhibits IL-1-induced NF-kappaB activation at the level of TRAF6.
Heyninck K; Beyaert R
FEBS Lett; 1999 Jan; 442(2-3):147-50. PubMed ID: 9928991
[TBL] [Abstract][Full Text] [Related]
39. Zinc-suppressed inflammatory cytokines by induction of A20-mediated inhibition of nuclear factor-κB.
Prasad AS; Bao B; Beck FW; Sarkar FH
Nutrition; 2011; 27(7-8):816-23. PubMed ID: 21035309
[TBL] [Abstract][Full Text] [Related]
40. Expression of the nuclear factor-κB inhibitor A20 is altered in the cystic fibrosis epithelium.
Kelly C; Williams MT; Mitchell K; Elborn JS; Ennis M; Schock BC
Eur Respir J; 2013 Jun; 41(6):1315-23. PubMed ID: 23018911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
